8-K filing — Atara Biotherapeutics, Inc. (ATRA)
Filed: 2026-08-12 AccNo: 0001193125-26-346857 Size: 455 KB Item 2.02: Results of Operations and Financial Condition
Read original at edgarStocks · News reference
Atara Biotherapeutics Q2 EPS $(0.32), Inline, Sales $630.000K Beat $366.667K Estimate
Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 268.42 percent decrease over earnings of $0.19 per share from the same period last
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 12, 2026, 8:25 PM
- Checked
- Aug 12, 2026, 8:25 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading